Promega Corporation

SignaTECT® Calcium/Calmodulin-Dependent Protein Kinase Assay System Technical Bulletin

  • Instructions for Use of Product(s)
  • V8161

Literature # TB279

The SignaTECT® Calcium/Calmodulin-Dependent Protein Kinase (CaM KII) Assay System provides an improved method to quantitate CaM KII protein kinase activity in both purified enzyme preparations and cell or tissue extracts. The SignaTECT® CaM KII System uses the unique SAM2® Biotin Capture Membrane, produced by a proprietary process that results in a high density of streptavidin on the membrane matrix.

The SignaTECT® CaM KII Assay System overcomes the problem of nonspecific substrate binding by using a biotinylated peptide that is selective for CaM KII in conjunction with the SAM2® Membrane. The high binding capacity of the SAM2® Membrane for the CaM KII biotinylated peptide substrate and low backgrounds observed with this system maximize the signal-to-noise ratio.

Printed in USA. Revised 1/13.

PDF Icon Complete Protocol PDF (551kb)

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.

Click Here for Technical Questions and Ordering Support »